SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-077384
Filing Date
2016-01-27
Accepted
2016-01-27 21:36:58
Documents
2
Period of Report
2015-08-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v429905_4.html 4  
1 OWNERSHIP DOCUMENT v429905_4.xml 4 3235
2 POWER OF ATTORNEY v429905_ex24.htm EX-24 8744
  Complete submission text file 0001144204-16-077384.txt   13644
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Issuer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC

Mailing Address 13 FOX MEADOW RD SCARSDALE NY 10583
Business Address
LOSORDO DOUGLAS W (Reporting) CIK: 0001583810 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 161366452